Published in Proc Natl Acad Sci U S A on October 01, 1990
Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev (2000) 8.24
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev (1999) 5.13
The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A (2003) 4.41
Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol (2009) 4.39
Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc Natl Acad Sci U S A (2001) 2.55
Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A (1998) 2.48
Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res (2004) 2.33
Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J (2001) 2.30
Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol (1993) 2.16
Glutamate antagonists limit tumor growth. Proc Natl Acad Sci U S A (2001) 1.88
Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci (2009) 1.87
Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer (1993) 1.68
Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis (1997) 1.62
Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta. Breast Cancer Res (2000) 1.54
Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J (2001) 1.47
Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? Breast Cancer Res Treat (2008) 1.41
Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225). EMBO J (1992) 1.38
Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res (2000) 1.38
Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. Cancer Res (2006) 1.35
Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancer. PLoS One (2010) 1.31
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol (1993) 1.19
Metastasis suppressor genes at the interface between the environment and tumor cell growth. Int Rev Cell Mol Biol (2011) 1.18
Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Res (2010) 1.18
Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer (1994) 1.13
Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J (1997) 1.13
Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/SMAD signaling defects and cancer. Breast Cancer Res (2000) 1.11
A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression. Proc Natl Acad Sci U S A (1994) 1.08
Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell (1999) 1.07
Identification of genes involved in cell invasion by using a library of randomized hybrid ribozymes. Proc Natl Acad Sci U S A (2003) 1.06
Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. BMC Cancer (2010) 1.05
Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer (1994) 1.05
Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells. Eur Arch Otorhinolaryngol (2007) 1.00
Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression. Biochem J (2001) 1.00
Genetic variants of Tgfb1 act as context-dependent modifiers of mouse skin tumor susceptibility. Proc Natl Acad Sci U S A (2006) 0.97
Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells. Mol Cell Biol (1994) 0.96
Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin Exp Metastasis (2007) 0.95
TGF-β induced TMEPAI/PMEPA1 inhibits canonical Smad signaling through R-Smad sequestration and promotes non-canonical PI3K/Akt signaling by reducing PTEN in triple negative breast cancer. Genes Cancer (2014) 0.93
Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas. Br J Cancer (1997) 0.92
TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103. Clin Exp Metastasis (2000) 0.91
Therapeutic effect of clarithromycin on a transplanted tumor in rats. Antimicrob Agents Chemother (1999) 0.91
Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma. Br J Cancer (1998) 0.91
Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer. Mol Cancer (2008) 0.91
Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol (1994) 0.90
Epithelial ovarian cancer: a cytokine propelled disease? Br J Cancer (1991) 0.89
Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Lab Invest (2014) 0.88
Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells. Br J Cancer (1996) 0.88
Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma. J Clin Pathol (1994) 0.86
Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol (1996) 0.86
Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy. Br J Cancer (1996) 0.85
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent. Ecancermedicalscience (2015) 0.85
Expression and mutational analysis of TGF-beta/Smads signaling in human cervical cancers. J Gynecol Oncol (2009) 0.84
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc (2009) 0.83
Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein. Sarcoma (2000) 0.82
TGFbeta-mediated signaling and transcriptional regulation in pancreatic development and cancer. Curr Opin Gastroenterol (2001) 0.82
Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts. Br J Cancer (1996) 0.82
FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer. Oncogene (2014) 0.82
The complexities of TGF-β action during mammary and squamous cell carcinogenesis. Curr Pharm Biotechnol (2011) 0.81
Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators. Br J Cancer (1993) 0.81
Enhancement of type IV collagenases by highly metastatic variants of HT1080 fibrosarcoma cells established by a transendothelial invasion system in vitro. Clin Exp Metastasis (1998) 0.81
TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer. Clin Exp Metastasis (2013) 0.81
The inhibition of tumor cell adhesion on human mesothelial cells (HOMC) by phospholipids in vitro. Langenbecks Arch Surg (2006) 0.80
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation. J Cancer (2015) 0.79
TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling. Int J Mol Med (2015) 0.79
CIIA functions as a molecular switch for the Rac1-specific GEF activity of SOS1. J Cell Biol (2011) 0.79
Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer (1999) 0.79
Basal localization of MT1-MMP is essential for epithelial cell morphogenesis in 3D collagen matrix. J Cell Sci (2014) 0.78
Down-regulation of TGF-beta1 production restores immunogenicity in prostate cancer cells. Br J Cancer (2000) 0.77
Evaluation of the interaction between TGF beta and nitric oxide in the mechanisms of progression of colon carcinoma. Clin Exp Metastasis (2005) 0.76
A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness. Oncotarget (2015) 0.76
Enhancement of lung-colonizing potential of murine tumor cell lines co-cultivated with activated macrophages. Clin Exp Metastasis (1997) 0.76
Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle. Exp Ther Med (2016) 0.75
Effects of transforming growth factor-beta in the development of inflammatory pseudotumour-like lesions in a murine model. Int J Exp Pathol (2006) 0.75
Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox. J Clin Med (2017) 0.75
Nanoparticulate delivery of agents for induced elastogenesis in three-dimensional collagenous matrices. J Tissue Eng Regen Med (2014) 0.75
Transforming growth factor β1 and diabetic nephropathy. Am J Physiol Renal Physiol (2015) 0.75
TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion. Int J Oncol (2017) 0.75
Detection of differentially expressed gelatinase A in metastatic and non-metastatic subpopulations of tumor cells by target RNA arbitrarily primed polymerase chain reaction (TRAP-PCR). Clin Exp Metastasis (1998) 0.75
The effect of CT26 tumor-derived TGF-β on the balance of tumor growth and immunity. Immunol Lett (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93
Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25
Growth factors and cancer. Cancer Res (1986) 3.48
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A (1986) 3.04
The TGF-beta family of growth and differentiation factors. Cell (1987) 2.86
Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A (1987) 2.50
Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell (1987) 2.41
Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem (1989) 2.05
A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett (1987) 1.94
Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst (1982) 1.93
Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta (1988) 1.75
Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci U S A (1989) 1.68
Heparanases and tumor metastasis. J Cell Biochem (1988) 1.64
Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Cancer Res (1988) 1.60
Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun (1988) 1.54
Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Cancer Res (1990) 1.45
Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta. J Cell Biol (1988) 1.44
Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res (1976) 1.44
Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. J Biol Chem (1985) 1.42
Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res (1987) 1.42
Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts. Cancer Res (1988) 1.40
Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) (1988) 1.24
The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. Int J Cancer (1988) 1.19
Tumor subpopulation interactions in metastasis. Invasion Metastasis (1983) 1.14
Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J Cell Biol (1989) 1.14
Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res (1989) 1.12
Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents. Int J Cancer (1989) 1.07
Integrin-receptor-mediated differentiation and growth inhibition are enhanced by transforming growth factor-beta in colorectal tumour cells grown in collagen gel. Int J Cancer (1989) 1.06
Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. Cancer Res (1989) 1.05
Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion Metastasis (1983) 1.00
Dynamic aspects of cancer cell populations in metastasis. Am J Pathol (1979) 0.99
Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. Cancer Res (1989) 0.95
Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents. Cancer Immunol Immunother (1985) 0.91
Heterogeneity of fibroblast response in host-tumor cell-cell interactions in metastatic tumors. J Cell Biochem (1987) 0.87
A solid-phase substrate of heparanase: its application to assay of human melanoma for heparan sulfate degradative activity. Anal Biochem (1986) 0.87
Potentiation and inhibition of tumor cell invasion by host cells and mediators. Invasion Metastasis (1989) 0.84
Alterations in phosphoinositide metabolism associated with 17 beta-estradiol and growth factor treatment of MCF-7 breast cancer cells. Mol Endocrinol (1988) 0.84
Transforming growth factors in the regulation of malignant cell growth and invasion. Cancer Invest (1988) 0.82
Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res (1988) 2.67
Comparative toxicology of trichothec mycotoxins: inhibition of protein synthesis in animal cells. J Biochem (1973) 2.45
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg (1999) 2.38
Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene (2006) 2.27
Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer (1991) 2.26
Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A (1995) 2.14
Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst (1990) 2.00
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci U S A (1993) 1.94
A new method for prosthetic valve replacement in congenital aortic stenosis associated with hypoplasia of the aortic valve ring. J Thorac Cardiovasc Surg (1975) 1.87
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem (1993) 1.87
Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway. APMIS (2000) 1.84
Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release (2001) 1.73
Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem (1999) 1.69
Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci U S A (1989) 1.68
Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer (1998) 1.65
Toxicological approaches to the metabolites of Fusaria. I. Screening of toxic strains. Jpn J Exp Med (1971) 1.64
Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science (1983) 1.63
Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem (1984) 1.61
Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest (2001) 1.60
Comparative study on skin-necrotizing effect of scirpene metabolites of Fusaria. Jpn J Exp Med (1970) 1.57
A naturally occurring functional allele of the rice waxy locus has a GT to TT mutation at the 5' splice site of the first intron. Plant J (1998) 1.54
Diurnal variation in microcirculation of ocular fundus and visual field change in normal-tension glaucoma. Eye (Lond) (2004) 1.54
The microtensile bond test: a review. J Adhes Dent (1999) 1.54
Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol (2012) 1.52
Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer (1993) 1.52
CT is useful for identifying patients with complicated appendicitis. Dig Liver Dis (2004) 1.50
Endoglin modulates cellular responses to TGF-beta 1. J Cell Biol (1996) 1.50
Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice. Eur Respir J (2005) 1.49
A pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int (2009) 1.48
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest (1994) 1.48
CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene (1999) 1.48
Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res (1988) 1.47
Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes. Drug Metab Dispos (1999) 1.45
Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection. Intern Med (2000) 1.44
Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res (1987) 1.42
Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int (1995) 1.39
Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry (2007) 1.38
Generation of 10,154 expressed sequence tags from a leafy gametophyte of a marine red alga, Porphyra yezoensis. DNA Res (2000) 1.32
FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer (2003) 1.32
Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation (1992) 1.26
A stereoselective synthesis of the C10-C31 (BCDEF ring) portion of pinnatoxin A. Org Lett (2001) 1.26
Solvent-induced dimensional changes in EDTA-demineralized dentin matrix. J Biomed Mater Res (2001) 1.25
Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol (1997) 1.23
Primary pulmonary primitive neuroectodermal tumor (PNET). A case report. Pathol Res Pract (2001) 1.21
The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc (1988) 1.21
Bonding of self-etch and total-etch adhesives to carious dentin. J Dent Res (2002) 1.20
Endoscopic ultrasonography in the diagnosis of submucosal tumor of the upper digestive tract. Scand J Gastroenterol Suppl (1986) 1.20
RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer (2006) 1.20
The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. Int J Cancer (1988) 1.19
Expression of endothelin receptor a associated with prostate cancer progression. J Urol (2001) 1.19
Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ (2000) 1.18
Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. Br J Clin Pharmacol (2000) 1.18
Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy (1993) 1.18
Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer (2001) 1.17
Surfer's ear in Japan. Laryngoscope (1989) 1.16
Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab Invest (1997) 1.15
Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol (2000) 1.14
Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF. J Allergy Clin Immunol (1999) 1.14
Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer (1993) 1.13
The rice bZIP transcriptional activator RITA-1 is highly expressed during seed development. Plant Cell (1994) 1.13
Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem J (1997) 1.13
Non-herpetic limbic encephalitis associated with relapsing polychondritis. J Neurol Neurosurg Psychiatry (2004) 1.13
Heparanase protein and gene expression in bladder cancer. J Urol (2001) 1.13
Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull (2000) 1.12
Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res (1996) 1.12
Purification and properties of an extracellular proteinase of psychrophilic Escherichia freundii. Eur J Biochem (1974) 1.12
Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin Exp Metastasis (1995) 1.12
Covalent modifications to 2'-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem Res Toxicol (1999) 1.11
Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene (2000) 1.10
Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res (2001) 1.10
Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors. Bioorg Med Chem (2001) 1.10
Differentiation between solitary brain metastasis and high-grade glioma by diffusion tensor imaging. Br J Radiol (2005) 1.10
Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res (2001) 1.09
Relationship between adhesive thickness and microtensile bond strength. Oper Dent (2001) 1.08
Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli. Microbiol Immunol (2000) 1.08
Globomycin, a new peptide antibiotic with spheroplast-forming activity. II. Isolation and physico-chemical and biological characterization. J Antibiot (Tokyo) (1978) 1.08
Determination of idebenone in rat serum and brain by high-performance liquid chromatography using platinum catalyst reduction and electrochemical detection. J Chromatogr (1992) 1.08
Diagnosis of submucosal lesions of the upper gastrointestinal tract by endoscopic ultrasonography. Gastrointest Endosc (1990) 1.08
In vivo and in vitro invasiveness of human lung carcinoma cell lines. Invasion Metastasis (1991) 1.08
Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer (2004) 1.07
Shape memory alloy catheter system for peroral pancreatoscopy using an ultrathin-caliber endoscope. Endoscopy (1994) 1.07
Analysis of a local fitness landscape with a model of the rough Mt. Fuji-type landscape: application to prolyl endopeptidase and thermolysin. Biopolymers (2000) 1.06
Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis (1995) 1.05
Isolated pulmonary arteriovenous fistula without Rendu-Osler-Weber disease as a cause of cryptogenic stroke. J Neurol Neurosurg Psychiatry (2004) 1.04
Globomycin, a new peptide antibiotic with spheroplast-forming activity. III. Structural determination of globomycin. J Antibiot (Tokyo) (1978) 1.04
Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc Natl Acad Sci U S A (1999) 1.04
High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol (1996) 1.03
The diagnosis of submucosal tumors of the stomach by endoscopic ultrasonography. Gastrointest Endosc (1989) 1.03
Adhesion to root canal dentine using one and two-step adhesives with dual-cure composite core materials. J Oral Rehabil (2005) 1.03
Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer (1998) 1.03
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother (1997) 1.02
The role of presenilin 1 during somite segmentation. Development (2001) 1.02
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. Clin Cancer Res (2001) 1.02
Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets. J Biol Chem (1989) 1.01
Interactions of thromboxane A2 analogs and prostaglandins in isolated dog arteries. J Cardiovasc Pharmacol (1986) 1.01
Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol (1998) 1.01
Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol (2001) 1.01